Australian Pharmaceutical Industries Limited
_________________________________________________________________________________
Australian Pharmaceutical Financial Snapshot
Industries Limited Operating Performance
Fast Facts The company reported revenue of US$3,143.02
million during the fiscal year 2011 (2011). The
company's revenue grew at a CAGR of 9.24% during
Headquarters Address 11 Grand Avenue, Camellia, 2142,Australia
2007–2011, with an annual decline of 7.56% over
2010. In 2011, the company recorded an operating
Telephone + 61 2 88442000
margin of -0.19%, as against 1.57% in 2010.
Fax + 61 2 88442896
Revenue and Margins
Website www.api.net.au
Ticker Symbol, Stock Exchange API, Australian Stock Exchange
Number of Employees 5,105
Fiscal Year End August
Revenue (in US$ million) 3,143.02
Revenue (in AUD million) 3,425.89
SWOT Analysis
Strengths Weaknesses
Presence across the value chain Limited geographic presence
Strong presence in pharmacy market Weak financial performance
Wide product and service portfolio
Opportunities Threats
Ageing population Rising labor wages
Business expansions Stringent regulations
Strong initiatives by competitors
___________________________________________________________________________________________
Australian Pharmaceutical Industries Limited - SWOT Page 1
Profile
Australian Pharmaceutical Industries Limited
_________________________________________________________________________________
TABLE OF CONTENTS
1 Business Analysis ................................................................................................................................... 5
1.1 Company Overview ................................................................................................................................................5
1.2 Business Description ..............................................................................................................................................5
1.3 Major Products and Services .................................................................................................................................6
2 Analysis of Key Performance Indicators ............................................................................................... 7
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
2.2 Key Financial Performance Indicators .................................................................................................................10
2.2.1 Revenue and Operating Profit .........................................................................................................................10
2.2.2 Asset, Liabilities and Capex .............................................................................................................................11
2.2.3 Net Debt vs. Gearing Ratio ..............................................................................................................................12
2.2.4 Solvency ..........................................................................................................................................................13
2.3 Key Competitors ...................................................................................................................................................14
3 Mergers & Acquisitions and Partnerships ........................................................................................... 15
3.1 M&A and Partnerships Strategy ...........................................................................................................................15
4 SWOT Analysis ...................................................................................................................................... 17
4.1 SWOT Analysis - Overview ..................................................................................................................................17
4.2 Strengths ..............................................................................................................................................................17
4.3 Weaknesses .........................................................................................................................................................17
4.4 Opportunities ........................................................................................................................................................18
4.5 Thre